scanning electron micrograph of electrospun material

Our development services

Accelerating your new product development

VIVOLTA’s iterative design thinking approach to new product development infuses every step with quality-by-design principles for rapid, scalable innovation.

VIVOLTA builds quality into every step of the product design process by ensuring only medical implant grade polymers are selected for development even at the earliest stages of feasibility testing. During development, we adhere to Design Control principles in accordance with our ISO13485 certification as a medical device component manufacturer. Importantly, our development team always incorporates design-for-manufacturing stress testing from the earliest phases of development to ensure all manufacturing processes are scalable and robust. At the (pre-)clinical manufacturing phase, our validated manufacturing processes are continuously monitored by integrated, automated quality systems embedded in the MediSpinTM production system – guaranteeing traceability of every part produced back to the specific polymer batch used to make it.

VIVOLTA's development services process.
From concept to commercial

Our proven approach to new product development

(1) Concept design: VIVOLTA works side-by-side the client to first understand the clinical need, then translating that need into design concepts made possible by medical electrospinning. 

(2) Feasibility testing: Applying design thinking mechanisms, rapid, iterative prototyping based on a ‘Build-Test-Learn’ paradigm ensures the most feasible concept efficiently proceeds into the development phase.

(3) Development: VIVOLTA applies a quality-by-design approach to its development activities according to Design Control principles. In this phase, VIVOLTA’s proprietary electrospinning equipment technology is leveraged and customized to meet the specific product design requirements at hand. Because of this, high quality, scalable manufacturing is designed in from the beginning of product development, not at the end.

(4) Scale-up & validation: Following product design freeze, the developed electrospinning process is transferred to a client-dedicated MediSpin production system in an ISO Class 7 cleanroom for scaled-up manufacturing. With íts fully integrated, automated quality systems, clinical-grade products are manufactured with full traceability and 100% automated inspection. 

(5) Commercial manufacturing: Upon market approval, VIVOLTA is qualified according to our ISO13485 accreditation to manufacture  commercial grade product in our ISO Class 7 cleanrooms. Our MediSpin production system offers in-line post-processing, such as laser cutting and packaging, for cost effective commercialization and a simplified supply chain for our clients.  

Our key competences

Driving innovation in development

At VIVOLTA, we can produce a wide variety of electrospun material forms ranging from flat meshes, tubes, and even complex 3D shapes using both natural and synthetic, resorbable and biostable polymers. Based on our broad portfolio of carefully selected medical materials, our bio- materials can be engineered to safely resorb over a period of time commensurate with tissue healing and restoration, or safely remain in the patient for a lifetime.

VIVOLTA’s innovative electrospun biomaterials instruct a more restorative response by the body, improving product performance and reducing complications. Our electrospun biomaterials add value to a wide range of medical applications including cardiovascular, orthopaedic sports medicine, general surgery and soft tissue reconstruction, advanced wound healing, and drug delivery.

Learn more

How can we help?

Contact us

How can VIVOLTA support your development or manufacturing project with best-in-class medical electrospinning services?

The MediSpin advantage

The MediSpin production platform transforms your electrospun medical device concept into a commercial reality.